The information in this website is intended only for healthcare professionals. By entering this site, you are confirming that you are a healthcare professional.
The information in this website is intended only for laboratory professionals. By entering this site, you are confirming that you are a laboratory professional.
The ImmunoCAPTM ISACTM solid-phase allergen chip assay is an in vitro test that allows for simultaneous measurement of specific IgE antibodies to 112 allergen components from 51 sources. This innovative assay provides clinicians with a significant amount of allergen-specific IgE antibody information in a single step, from a single sample. The assay is clinically documented in more than 220 peer reviewed articles, including a global validation study.1 The ImmunoCAP ISAC test is the result of a combination of innovative biochip technology and cutting-edge research in molecular allergology.
Based on modern biochip technology, ImmunoCAP ISAC assay is an immunoassay platform in which allergen components are immobilized in a microarray. This test is a two-step assay that can be completed in less than 4 hours:
IgE antibodies from the patient sample bind to the immobilized allergen components
Allergen-bound IgE antibodies are detected by a fluorescence labeled anti-IgE antibody
*In the US, testing with ImmunoCAP ISAC is available only through PiRL. More information >